Actively Recruiting
Standardization of Spatial Neglect Assessment Tests
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-02-10
210
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Spatial neglect is a common cognitive disorder in stroke patients, characterized by a lateralized deficit in attention and intention. This research focuses on defining norms for tests to assess spatial neglect. The norms correspond to the results obtained in a population free of any disorder that could have an impact on test performance. These results can vary in a normal, non-pathological way, with certain parameters such as age, sex, laterality or level of education. Defining these norms in healthy volunteers is therefore essential for interpreting results in patients suspected of spatial neglect, and in particular for defining pathological thresholds above which the diagnosis of spatial neglect can be retained. To answer the research question, we plan to include 210 people with no central neurological disease (stroke, epilepsy and multiple sclerosis in particular), in a single-center study in the neurovascular department of the Raymond-Poincaré hospital (Garches). The 210 subjects will be divided into 10-year age groups, from 20 to 89 years, with the recruitment of 30 participants per age group (15 men and 15 women): 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, 80-89 years.
CONDITIONS
Official Title
Standardization of Spatial Neglect Assessment Tests
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy volunteer attending the neurovascular department of Raymond-Poincaré Hospital
- Aged between 20 and 89 years
- Affiliated with a health insurance scheme
- French-speaking
- Has freely and knowingly expressed their non-opposition
You will not qualify if you...
- Known history of central neurological disease such as stroke, transient ischemic attack, encephalitis, multiple sclerosis, or epilepsy
- Medical history suggesting past central nervous system problems like sensorimotor deficits, speech or vision issues, or hallucinations
- Significant vision impairment in near vision despite correction or blindness in one eye
- Abnormal neurological exam including NIH Stroke Scale score above 0 or pyramidal reflex syndrome
- Use of alcohol or drugs within 24 hours before assessment
- Presence of cognitive or psychiatric disorders as assessed by the examiner
- Language barrier or aphasia
- Participant under legal protection such as guardianship or curatorship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Raymond Poincarré
Garche, France, 92380
Actively Recruiting
Research Team
J
Jean-Baptiste BRUNET de COURSSOU, Dr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here